Ulrich Haupts

Biography

Ulrich Haupts joined Scil Proteins in 2011 as CSO. In 2013 he was then appointed to the additional role of Managing Director. He is responsible for the technical development of the Affilin® platform as well as internal and external projects. Dr. Haupts has more than 15 years of industry experience gained in large pharma as well as biotech companies. At Bayer Healthcare he held the position of Director of Protein Optimization for three years. Prior to that, he spent seven years as Vice President of R&D Biopharmaceuticals at Direvo Biotech (which was subsequently acquired by Bayer Healthcare in 2008). In addition, Dr. Haupts also worked for three years at SmithKline Beecham UK in the New Assay Technology group. Previously, he carried out a two-year post-doctoral fellowship at Cornell University working in the field of mass spectrometry and fluorescence correlation spectroscopy. Dr. Haupts received his PhD in 1996 from the Max-Planck Institute for Biochemistry, Martinsried, Germany.

Research Interest

Biochemistry